evidence disease metastatic radiologic clinical definitive imaging patients time residual 
lipase uln serum times institutional registration pancreatitis capmatinib screened institutions 
lipase pancreatitis radiologic clinical evidence uln upper limit normal cabozantinib 
amylase pancreatitis lipase history increased pancreatic symptoms uln cholecystitis suggestive